Mark R. Hutchins, M.D.   I   Daniel F. Moravec, Jr., M.D.   I   Joni A. Tilford, M.D.   I   Madhu V. Midathada, M.D.
 
Cancer Care
Types of Cancer
Cancer Treatment
Blood Disorders
Your Medical Team
About You
About Us
Clinical Trials
Cancer News
Resources
Glossary
Home
 
Melanoma

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (08/09/2010)
A systematic review of 47 studies evaluating treatment for melanoma, head and neck cancer, genitourinary cancers, gynecologic cancers, and sarcoma indicates that lymphedema is a common side effect of treatment for these diseases.

Study Evaluates Melanoma Trends in High-risk Region of United States (07/27/2010)
Melanoma incidence in Hispanic men and African-American women residing in Florida may be higher than in other regions of the United States. These findings were recently published in the journal Archives of Dermatology.

Ipilimumab Improves Outcomes in Advanced Melanoma (06/07/2010)
Among patients with previously treated, advanced melanoma, treatment with the investigational drug ipilimumab improved overall and progression-free survival. The results of this Phase III clinical trial were presented at the 2010 annual meeting of the American Society of Clinical Oncology.

More Evidence that Indoor Tanning Increases Risk of Melanoma (06/04/2010)
Frequent indoor tanning increases the risk of developing melanoma, according to results recently published in the journal Cancer Epidemiology, Biomarkers & Prevention.

How Much Follow-up Is Appropriate for Melanoma Survivors? (06/02/2010)
Once survivors of Stage III melanoma reach a certain time period of recovery, the frequency and intensity of follow-up does not appear to be associated with discovery of resectable first relapses, according to the results of a study published early online in the Journal of Clinical Oncology.

May Is National Skin Cancer Awareness Month 2010 (05/03/2010)
As the month of May brings skin cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated skin cancer information throughout the year.

Latest Melanoma by Stage
Recurrent
Screening/Prevention

Study Evaluates Melanoma Trends in High-risk Region of United States (07/27/2010)
Melanoma incidence in Hispanic men and African-American women residing in Florida may be higher than in other regions of the United States. These findings were recently published in the journal Archives of Dermatology.

More Evidence that Indoor Tanning Increases Risk of Melanoma (06/04/2010)
Frequent indoor tanning increases the risk of developing melanoma, according to results recently published in the journal Cancer Epidemiology, Biomarkers & Prevention.

Stage III

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (08/09/2010)
A systematic review of 47 studies evaluating treatment for melanoma, head and neck cancer, genitourinary cancers, gynecologic cancers, and sarcoma indicates that lymphedema is a common side effect of treatment for these diseases.

Ipilimumab Improves Outcomes in Advanced Melanoma (06/07/2010)
Among patients with previously treated, advanced melanoma, treatment with the investigational drug ipilimumab improved overall and progression-free survival. The results of this Phase III clinical trial were presented at the 2010 annual meeting of the American Society of Clinical Oncology.

How Much Follow-up Is Appropriate for Melanoma Survivors? (06/02/2010)
Once survivors of Stage III melanoma reach a certain time period of recovery, the frequency and intensity of follow-up does not appear to be associated with discovery of resectable first relapses, according to the results of a study published early online in the Journal of Clinical Oncology.

Stage IV

Ipilimumab Improves Outcomes in Advanced Melanoma (06/07/2010)
Among patients with previously treated, advanced melanoma, treatment with the investigational drug ipilimumab improved overall and progression-free survival. The results of this Phase III clinical trial were presented at the 2010 annual meeting of the American Society of Clinical Oncology.

Stages I-II

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (08/09/2010)
A systematic review of 47 studies evaluating treatment for melanoma, head and neck cancer, genitourinary cancers, gynecologic cancers, and sarcoma indicates that lymphedema is a common side effect of treatment for these diseases.

4004 Pioneer Woods Dr., Lincoln, NE 68506   I   402.484.4900   I   Toll Free: 877.436.3662
Cancer Care   I   Types of Cancer   I   Cancer Treatment   I   Blood Disorders   I   Your Medical Team   I   About You   I   About Us
Clinical Trials   I    Cancer News   I  Resources   I   Glossary   I   Privacy Statement   I   Home